(NASDAQ: NAUT) NAUTILUS BIOTECHNOLOGY's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 17.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.29%.
NAUTILUS BIOTECHNOLOGY's revenue in 2022 is $0.On average, 2 Wall Street analysts forecast NAUT's revenue for 2022 to be $242,700,223, with the lowest NAUT revenue forecast at $99,569,322, and the highest NAUT revenue forecast at $385,831,124. On average, 2 Wall Street analysts forecast NAUT's revenue for 2023 to be $1,721,304,661, with the lowest NAUT revenue forecast at $1,618,001,489, and the highest NAUT revenue forecast at $1,824,607,833.
In 2024, NAUT is forecast to generate $8,401,161,578 in revenue, with the lowest revenue forecast at $8,401,161,578 and the highest revenue forecast at $8,401,161,578.